Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Fertility specialist Monash IVF (MVF) is joining the list of companies getting rid of its FY20 earnings guidance
  • As COVID-19 spreads, the company said it is tough to predict how it will perform in the fourth quarter of the financial year
  • Nevertheless, the Fertility Society of Australia has said there is no need for extra concern among those trying to conceive
  • As such, Monash is operating as per normal for now, but has preemptive measures in place to protect patients and employees
  • Shares in Monash fell 15.7 per cent to 51 cents each today

Fertility specialist Monash IVF (MVF) is joining the growing list of companies tossing away their earnings guidance as COVID-19 spreads.

The company said while the pandemic has not strictly impacted business operations yet, the uncertainty of market activity going into the fourth quarter of the year makes an accurate guidance tough to predict.

In its half-yearly report from February 21, Monash said it was on track to meet its predicted 2020 net profit after tax of between $18 million and $19 million.

The company’s profit for the first half of the financial year fell marginally above expectations, but Monash is not so sure things will go the same way in the second half.

As it stands, the Fertility Society of Australia has recommended those trying to conceive have no need for extra concern amid growing COVID-19 scares.

“At this point, there is no evidence to recommend contraception or cessation of attempts to conceive, either unassisted or assisted,” the Society said.

As such, Monash’s IVF and women’s imaging services are proceeding as per normal for the meantime.

Nevertheless, Monash has taken pre-emptive measures to ensure both the health and safety of patients and doctors and the protection of its business.

Monash said it will update the market with any news on business impacts from the coronavirus as appropriate.

Despite the “business as usual” tone in the company’s announcement, investors reacted negatively to today’s news. Shares in Monash fell 15.7 per cent to 51 cents each today — bring their total loss since the start of 2020 to 50.49 per cent.

MVF by the numbers
More From The Market Herald

" Anatara Lifesciences (ASX:ANR) expands eligibility criteria for IBS and psychological functioning trials

Anatara Lifesciences (ASX:ANR) has received ethics approval to expand eligibility criteria for its Irritable Bowel Syndrome…

" Althea (ASX:AGH) enters Irish medicinal cannabis market

Althea (ASX:AGH) has received approval from the Health Products Regulatory Authority (HPRA) for its CBD12:THC10 product…

" Apiam Animal Health (ASX:AHX) executes growth strategy with two acquisitions

Apiam Animal Health (ASX:AHX) has announced new acquisitions as part of its growth strategy to double…

" Next Science (ASX:NXS) appoints Oraderm Pharmaceuticals as BlastX distributor

Next Science (ASX:NXS) has signed a multi-year distribution agreement for the sale and distribution of its…